Clinical trials
Phase 2 Infertility, Male trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Unknown status | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Weill Medical College of Cornell University | 3 |
| Martin Blomberg Jensen | 2 |
| University of Washington | 2 |
| Al-Mustansiriyah University | 1 |
| Azienda Ospedaliero-Universitaria di Modena | 1 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Hamilton Health Sciences Corporation | 1 |
| Jinling Hospital, China | 1 |
| KK Women's and Children's Hospital | 1 |
| Prokrea BCN, S.L. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Infertility, Male | 19 |
| Infertility | 4 |
| Azoospermia | 3 |
| Obesity | 3 |
| Oligospermia | 3 |
| Hypogonadism | 2 |
| Asthenozoospermia | 1 |
| Chronic Pain | 1 |
| Endocrine System Diseases | 1 |
| Inflammation | 1 |
Trials
Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.